CMSL

AcronymDefinition
CMSLCape May Seashore Lines (tourist railroad; New Jersey)
CMSLContent Management Services Layer
CMSLCascade Middle School League (Bellevue, WA)
CMSLCanadian Midstream Services Ltd.
CMSLContract Management Services Limited (Canada)
CMSLCredit Market Services Limited (India)
References in periodicals archive ?
CMSL provides Inyx with a base of new customers and new development and production capabilities in solid dose, sterile, injectible and dry powder inhaler products for the United Kingdom, Europe and Asia.
CMSL now operates under Inyx Europe Limited, a newly formed, wholly owned subsidiary that also includes Inyx Pharma Limited.
CMSL has over 50 years of experience in pharmaceutical development and manufacturing, and today produces a portfolio of branded and non-branded products for UCB and a number of third parties.
As part of Inyx's acquisition of CMSL, Inyx is receiving a five-year manufacturing contract from the UCB Group as well as a long-term product support and services contract.
McCusker called helping Team Massachusetts to a third-place finish this season, as well as defending her CMSL title, her most memorable moments.
These are the critical areas we address within the CMSL, so we can translate their centralization and compliance-driven needs into the proper technology implementation that will ensure highly effective document management within the eDOCs system.
The Nevis Gas Plant is 100% owned and operated by CMSL, has a processing capacity of 150 mmcf/d and offers customers a full range of services including transportation via a gathering system consisting of 300 kms of 4 to 12 inch pipelines, inlet compression, sweetening and liquid recovery and fractionation.
CMSL is a private Calgary-based midstream company that specializes in the acquisition, construction and operation of energy processing and transportation facilities.
Subject to completion of certain on-going due diligence subject to be completed by August 31, 1998, ENDV will issue an unspecified number of ENDV shares in a tax-free exchange of 100 percent of CMSL issued and outstanding shares.
CMSL is negotiating control of two companies that design, install and support computer-based clinical documentation systems for use in hospital, sophisticated implantable biosensor monitors and receivers for instantaneous and non-invasive readings of glucose levels and other biometric dosimetries, including circulating levels of Prostaglandin (PGE-1) for treating heart disease.